• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑变性对工作效率的影响:一项荟萃分析。

The effects of age-related macular degeneration on work productivity: A meta-analysis.

作者信息

Tran Edward, Nayeni Manav, Shah Nirmit, Malvankar-Mehta Monali S

机构信息

Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Canada.

Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.

出版信息

Eur J Ophthalmol. 2024 May;34(3):641-648. doi: 10.1177/11206721231185808. Epub 2023 Jul 14.

DOI:10.1177/11206721231185808
PMID:37448315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11067424/
Abstract

Age-related macular degeneration (AMD) is one of the leading causes of vision loss and blindness in older adults. Given the aging population in developed countries and the increased participation of older adults in the labour market, this paper aims to understand the impact of AMD on workplace productivity. Economic studies, comparative studies, observational studies, cohort studies, case series, randomized control trials, clinical trials, multicenter studies from MEDLINE, EMBASE, and CINHAL, as well as grey literature, were systematically searched to obtain all relevant literature. Duplicate records were removed, and two independent reviewers screened records for relevance. After screening, a risk of bias assessment was carried out. Data were extracted and a meta-analysis was performed using STATA 15.0. Fixed-effect and random-effect models were computed based on heterogeneity. Seven studies consisting of 3,060,864 subjects from 5 different countries were included in this systematic review. Mean wages lost due to impaired work productivity ranged from $1,395 to $55,180. The mean unemployment rate attributed to AMD ranged from 5.50% to 77.00%. Meta-analysis results indicated a significant unemployment rate (SMD = 0.44, CI: [0.27, 0.62]). Patients with AMD experience impaired work productivity as demonstrated by the wages lost and significantly higher rates of unemployment.

摘要

年龄相关性黄斑变性(AMD)是老年人视力丧失和失明的主要原因之一。鉴于发达国家人口老龄化以及老年人劳动力市场参与度的提高,本文旨在了解AMD对工作场所生产力的影响。系统检索了MEDLINE、EMBASE和CINHAL数据库中的经济研究、比较研究、观察性研究、队列研究、病例系列、随机对照试验、临床试验、多中心研究以及灰色文献,以获取所有相关文献。去除重复记录后,由两名独立评审员筛选记录的相关性。筛选后,进行了偏倚风险评估。提取数据并使用STATA 15.0进行荟萃分析。根据异质性计算固定效应模型和随机效应模型。本系统评价纳入了来自5个不同国家的7项研究,共3,060,864名受试者。因工作效率受损导致的平均工资损失在1,395美元至55,180美元之间。归因于AMD的平均失业率在5.50%至77.00%之间。荟萃分析结果显示存在显著的失业率(标准化均值差=0.44,置信区间:[0.27, 0.62])。如工资损失和显著更高的失业率所示,AMD患者的工作效率受损。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e21e/11067424/2d67ab2c6a51/10.1177_11206721231185808-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e21e/11067424/0e11db511204/10.1177_11206721231185808-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e21e/11067424/208dc34877c5/10.1177_11206721231185808-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e21e/11067424/2d67ab2c6a51/10.1177_11206721231185808-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e21e/11067424/0e11db511204/10.1177_11206721231185808-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e21e/11067424/208dc34877c5/10.1177_11206721231185808-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e21e/11067424/2d67ab2c6a51/10.1177_11206721231185808-fig3.jpg

相似文献

1
The effects of age-related macular degeneration on work productivity: A meta-analysis.年龄相关性黄斑变性对工作效率的影响:一项荟萃分析。
Eur J Ophthalmol. 2024 May;34(3):641-648. doi: 10.1177/11206721231185808. Epub 2023 Jul 14.
2
Blue-light filtering intraocular lenses (IOLs) for protecting macular health.用于保护黄斑健康的蓝光滤过型人工晶状体
Cochrane Database Syst Rev. 2018 May 22;5(5):CD011977. doi: 10.1002/14651858.CD011977.pub2.
3
Aflibercept for neovascular age-related macular degeneration.阿柏西普用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2.
4
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.抗氧化维生素和矿物质补充剂用于延缓年龄相关性黄斑变性的进展。
Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD000254. doi: 10.1002/14651858.CD000254.pub4.
5
Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.用于预防年龄相关性黄斑变性的抗氧化维生素和矿物质补充剂。
Cochrane Database Syst Rev. 2017 Jul 30;7(7):CD000253. doi: 10.1002/14651858.CD000253.pub4.
6
Surgery for cataracts in people with age-related macular degeneration.年龄相关性黄斑变性患者的白内障手术
Cochrane Database Syst Rev. 2017 Feb 16;2(2):CD006757. doi: 10.1002/14651858.CD006757.pub4.
7
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.雷珠单抗和哌加他尼治疗年龄相关性黄斑变性:系统评价与经济学评估
Health Technol Assess. 2008 May;12(16):iii-iv, ix-201. doi: 10.3310/hta12160.
8
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.预防性使用非甾体抗炎药预防白内障手术后黄斑水肿。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD006683. doi: 10.1002/14651858.CD006683.pub3.
9
Statins for age-related macular degeneration.用于年龄相关性黄斑变性的他汀类药物。
Cochrane Database Syst Rev. 2016 Aug 4;2016(8):CD006927. doi: 10.1002/14651858.CD006927.pub5.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Determinants of Healthcare Professionals' Knowledge on Age-Related Macular Degeneration Risk Factors in Ethiopia.埃塞俄比亚医疗保健专业人员对年龄相关性黄斑变性风险因素的认知决定因素
Clin Ophthalmol. 2025 Jun 4;19:1771-1785. doi: 10.2147/OPTH.S514480. eCollection 2025.
2
Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US.保加利亚、德国和美国晚期年龄相关性黄斑变性的经济负担
JAMA Ophthalmol. 2024 Dec 1;142(12):1123-1130. doi: 10.1001/jamaophthalmol.2024.4401.

本文引用的文献

1
Impact of neovascular age-related macular degeneration: burden of patients receiving therapies in Japan.与年龄相关的新生血管性黄斑变性的影响:在日本接受治疗的患者的负担。
Sci Rep. 2021 Jun 23;11(1):13152. doi: 10.1038/s41598-021-92567-4.
2
Global economic productivity losses from vision impairment and blindness.视力损害和失明造成的全球经济生产力损失。
EClinicalMedicine. 2021 Apr 26;35:100852. doi: 10.1016/j.eclinm.2021.100852. eCollection 2021 May.
3
Socioeconomic risk factors and age-related macular degeneration in the UK Biobank study.
英国生物银行研究中的社会经济风险因素与年龄相关性黄斑变性
BMJ Open Ophthalmol. 2021 Feb 23;6(1):e000585. doi: 10.1136/bmjophth-2020-000585. eCollection 2021.
4
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.2020 年失明和视力障碍的原因及 30 多年来的趋势,以及与 VISION 2020:看见的权利相关的可避免盲的患病率:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.
5
The burden of neovascular age-related macular degeneration: a patient's perspective.新生血管性年龄相关性黄斑变性的负担:患者视角
Clin Ophthalmol. 2018 Dec 4;12:2483-2491. doi: 10.2147/OPTH.S185052. eCollection 2018.
6
The economic and humanistic burden of patients in receipt of current available therapies for nAMD.接受现有湿性年龄相关性黄斑变性治疗的患者的经济和人文负担。
J Comp Eff Res. 2018 Nov;7(11):1125-1132. doi: 10.2217/cer-2018-0058. Epub 2018 Sep 21.
7
Utility values for age-related macular degeneration patients in Korea.韩国年龄相关性黄斑变性患者的效用值。
PLoS One. 2018 Jul 31;13(7):e0201399. doi: 10.1371/journal.pone.0201399. eCollection 2018.
8
A Systematic Review of the Treat and Extend Treatment Regimen with Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration.抗血管内皮生长因子药物治疗并延长治疗方案用于新生血管性年龄相关性黄斑变性的系统评价
Ophthalmol Ther. 2017 Jun;6(1):79-92. doi: 10.1007/s40123-017-0087-5. Epub 2017 Apr 27.
9
The impact of typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy on vision-related quality of life in Asian patients.典型性新生血管性年龄相关性黄斑变性和息肉状脉络膜血管病变对亚洲患者视力相关生活质量的影响。
Br J Ophthalmol. 2017 May;101(5):591-596. doi: 10.1136/bjophthalmol-2016-308541. Epub 2016 Aug 2.
10
SOCIETAL COSTS ASSOCIATED WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN THE UNITED STATES.美国与新生血管性年龄相关性黄斑变性相关的社会成本。
Retina. 2016 Feb;36(2):285-98. doi: 10.1097/IAE.0000000000000717.